Clinical Trial Update: Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing BI 695502 plus chemotherapy to Avastin plus chemotherapy in non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• BI 695502 (BI 695502)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED | Results posted: 2020-01-13